ResApp Health Limited and Ilara Health announced that Ilara Health will conduct a three month evaluation of ResAppDx, ResApp's smartphone app for acute respiratory disease diagnosis, at five partner medical facility sites in Kenya. The evaluation is expected to start during the third quarter of this calendar year. Over 500 million people in Africa struggle to access high quality healthcare, with many doctors across the continent having a limited ability to perform diagnostics in their clinic. According to the WHO, lower respiratory tract infections are the leading cause of death in Africa, resulting in nearly a million deaths in 2016.